March 2010 
Volume 40  Number 3
Pages 17 - 17
  PDF Version Available!

Researchers suggest that angiotensin receptor blockers (ARBs), commonly used to treat hypertension and heart failure, may decrease the risk of developing Alzheimer disease and dementia.Over a 4-year period, researchers studied 819,491 mostly male patients age 65 and older with cardiovascular disease taking ARBs, the angiotensin-converting enzyme (ACE) inhibitor lisinopril, or other cardiovascular drugs (the cardiovascular comparator). They found that those taking ARBs, especially candesartan, were significantly less likely to develop Alzheimer disease or dementia than patients in the other groups. In patients with preexisting Alzheimer disease, ARBs were associated with a significantly lower risk of admission to a long-term-care facility or death when compared with the cardiovascular comparator.Source: Li N, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominately male population: prospective cohort analysis. Brit Med J. 2010;340:b5465.Recent

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events